Science Daily -
13 Jun 2016 22:50
Non-small cell lung cancers (NSCLC) have a collective reputation for not responding very well to chemotherapy. Researchers now report a means of evaluating an immunotherapy that fights off NSCLC by strengthening a patient's own immune system.
Share this Article